Press Releases Forte Biosciences, Inc.

Equities

FBRX

US34962G1094

Delayed Nasdaq Other stock markets 18:41:39 26/06/2024 BST			5-day change	1st Jan Change
0.48 ^USD	+4.35%		-4.00%	-41.58%

05-30	Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target	MT
05-13	Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Forte Biosciences : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE Form 8 K	06-14	PU
Forte Biosciences Reports Inducement Grants Under Nasdaq Listing Rules	05-20	AQ
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules	05-17	BU
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update	05-13	BU
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update	03-18	BU
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules	12-01	BU
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update	11-13	BU
ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting	14/09/23	BU
Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom	06/09/23	BU
Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders	25/08/23	BU
Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update	14/08/23	BU
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102	01/08/23	BU
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules	19/05/23	BU
Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update	15/05/23	BU
FORTE BIOSCIENCES, INC. : Financial Statements and Exhibits (form 8-K)	31/03/23	AQ
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update	31/03/23	BU
FORTE BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	31/03/23	AQ
FORTE BIOSCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	09/02/23	AQ
Forte Biosciences, Inc. - Mr. David Gryska Appointed to Forte Biosciences Board of Directors	13/01/23	AQ
FORTE BIOSCIENCES, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	12/01/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Forte Biosciences, Inc.

Equities

FBRX

US34962G1094

Press Releases

Filters